Abstract
SUMO processing and deconjugation are essential proteolytic activities for nuclear metabolism and cell-cycle progression in yeast and higher eukaryotes. To elucidate the mechanisms used during substrate lysine deconjugation, SUMO isoform processing and SUMO isoform interactions, X-ray structures were determined for a catalytically inert SENP2 protease domain in complex with conjugated RanGAP1–SUMO-1 or RanGAP1–SUMO-2, or in complex with SUMO-2 or SUMO-3 precursors. Common features within the active site include a 90° kink proximal to the scissile bond that forces C-terminal amino acid residues or the lysine side chain toward a protease surface that appears optimized for lysine deconjugation. Analysis of this surface reveals SENP2 residues, particularly Met497, that mediate, and in some instances reverse, in vitro substrate specificity. Mutational analysis and biochemistry provide a mechanism for SENP2 substrate preferences that explains why SENP2 catalyzes SUMO deconjugation more efficiently than processing.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425–479 (1998).
Kerscher, O., Felberbaum, R. & Hochstrasser, M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22, 159–180 (2006).
Saitoh, H., Pu, R.T. & Dasso, M. SUMO-1: wrestling with a new ubiquitin-related modifier. Trends Biochem. Sci. 22, 374–376 (1997).
Owerbach, D., McKay, E.M., Yeh, E.T., Gabbay, K.H. & Bohren, K.M. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem. Biophys. Res. Commun. 337, 517–520 (2005).
Tatham, M.H. et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368–35374 (2001).
Cheng, C.H. et al. SUMO modifications control assembly of synaptonemal complex and polycomplex in meiosis of Saccharomyces cerevisiae. Genes Dev. 20, 2067–2081 (2006).
Melchior, F., Schergaut, M. & Pichler, A. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem. Sci. 28, 612–618 (2003).
Yeh, E.T., Gong, L. & Kamitani, T. Ubiquitin-like proteins: new wines in new bottles. Gene 248, 1–14 (2000).
Yamaguchi, T. et al. Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development. Mol. Cell. Biol. 25, 5171–5182 (2005).
Di Bacco, A. et al. The SUMO-specific protease SENP5 is required for cell division. Mol. Cell. Biol. 26, 4489–4498 (2006).
Bailey, D. & O'Hare, P. Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J. Biol. Chem. 279, 692–703 (2004).
Hang, J. & Dasso, M. Association of the human SUMO-1 protease SENP2 with the nuclear pore. J. Biol. Chem. 277, 19961–19966 (2002).
Nishida, T., Tanaka, H. & Yasuda, H. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 267, 6423–6427 (2000).
Zhang, H., Saitoh, H. & Matunis, M.J. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol. Cell. Biol. 22, 6498–6508 (2002).
Gong, L. & Yeh, E.T. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J. Biol. Chem. 281, 15869–15877 (2006).
Kim, K.I. et al. A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J. Biol. Chem. 275, 14102–14106 (2000).
Li, S.J. & Hochstrasser, M. The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol. Cell. Biol. 20, 2367–2377 (2000).
Panse, V.G., Kuster, B., Gerstberger, T. & Hurt, E. Unconventional tethering of Ulp1 to the transport channel of the nuclear pore complex by karyopherins. Nat. Cell Biol. 5, 21–27 (2003).
Nishida, T., Kaneko, F., Kitagawa, M. & Yasuda, H. Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation. J. Biol. Chem. 276, 39060–39066 (2001).
Reverter, D. & Lima, C.D. A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. Structure 12, 1519–1531 (2004).
Gong, L., Millas, S., Maul, G. & Yeh, E.T. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275, 3355–3359 (2000).
Shen, L.N., Dong, C., Liu, H., Naismith, J.H. & Hay, R.T. The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing. Biochem. J. 397, 279–288 (2006).
Mossessova, E. & Lima, C.D. Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol. Cell 5, 865–876 (2000).
Xu, Z. et al. Crystal structure of the SENP1 mutant C603S-SUMO complex reveals the hydrolytic mechanism of SUMO specific protease. Biochem. J. 398, 345–352 (2006).
Rodriguez, M.S., Dargemont, C. & Hay, R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654–12659 (2001).
Sampson, D.A., Wang, M. & Matunis, M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276, 21664–21669 (2001).
Bernier-Villamor, V., Sampson, D.A., Matunis, M.J. & Lima, C.D. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108, 345–356 (2002).
Lin, D. et al. Identification of a substrate recognition site on Ubc9. J. Biol. Chem. 277, 21740–21748 (2002).
Reverter, D. & Lima, C.D. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 435, 687–692 (2005).
Yunus, A.A. & Lima, C.D. Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway. Nat. Struct. Mol. Biol. 13, 491–499 (2006).
Rousseau, F., Schymkowitz, J.W. & Itzhaki, L.S. The unfolding story of three-dimensional domain swapping. Structure 11, 243–251 (2003).
Nicholls, A., Sharp, K.A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11, 281–296 (1991).
Johnston, S.C., Larsen, C.N., Cook, W.J., Wilkinson, K.D. & Hill, C.P. Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 Å resolution. EMBO J. 16, 3787–3796 (1997).
Johnston, S.C., Riddle, S.M., Cohen, R.E. & Hill, C.P. Structure basis for the specificity of ubiquitin c-terminal hydrolases. EMBO J. 18, 3877–3887 (1999).
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
Collaborative Computational Project, No. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760–763 (1994).
Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–118 (1991).
Brünger, A.T. et al. Crystallography and NMR System—a new software suite for macromolecular and structure determination. Acta Crystallogr D Biol. Crystallogr. 54, 905–921 (1998).
Laskowski, R., MacArthur, M., Hutchinson, E. & Thorton, J. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 283–291 (1993).
Navaza, J. An automated package for molecular replacement. Acta Crystallogr. A 50, 157–163 (1994).
DeLano, W.L. The PyMOL Molecular Graphics System (DeLano Scientific, San Carlos, California, USA, 2002).
Acknowledgements
Use of the APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. Use of the SGX Collaborative Access Team (SGX-CAT) beamline facilities at Sector 31 of the APS was provided by SGX Pharmaceuticals, Inc., who constructed and operates the facility. Use of the NE-CAT beamline at Sector 24 is based upon research conducted at the Northeastern Collaborative Access Team beamlines of the APS, which is supported by award RR-15301 from the National Center for Research Resources at the US National Institutes of Health (NIH). Beamline X29A at the National Synchrotron Light Source is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy and the National Center for Research Resources of the NIH. D.R. and C.D.L. are supported in part by NIH grant GM65872. D.R. acknowledges support from the Charles H. Revson Foundation and C.D.L. acknowledges support from the Rita Allen Foundation.
Author information
Authors and Affiliations
Contributions
D.R. generated the data. D.R. and C.D.L interpreted the data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Sequence alignment for Senp/Ulp and SUMO family members. (PDF 67 kb)
Supplementary Fig. 2
Domain-swapped RanGAP1 structures. (PDF 630 kb)
Rights and permissions
About this article
Cite this article
Reverter, D., Lima, C. Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates. Nat Struct Mol Biol 13, 1060–1068 (2006). https://doi.org/10.1038/nsmb1168
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb1168
This article is cited by
-
Validation of catalytic site residues of Ubiquitin Specific Protease 2 (USP2) by molecular dynamic simulation and novel kinetics assay for rational drug design
Molecular Diversity (2023)
-
Genetic insights into resting heart rate and its role in cardiovascular disease
Nature Communications (2023)
-
SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells
Archives of Toxicology (2022)
-
Protein–Protein Affinity Determination by Quantitative FRET Quenching
Scientific Reports (2019)
-
Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS–STING signalling
Nature (2019)